Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Endocrine Society of Thailand | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Hypothesis:
Artificial sweeteners such as sucralose, are among the most widely used food additives worldwide. Artificial sweetener consumption is considered safe and beneficial owing to their low caloric content. However, many emerging evidences showed artificial sweeteners may induce glucose intolerance. The objectives of this study were to determine the effect of sucralose on glycemic response, insulin secretion, insulin sensitivity, incretin response, gut microbiota and food behavior in healthy subjects.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sucralose | Experimental | Subjects in this group ate capsule filled with sucralose 200 mg for 4 weeks (week 1-4) and measured oral glucose tolerance test (OGTT), acute insulin response (AIR), and gut microbe examination at week 4. |
|
| Placebo | Placebo Comparator | Subjects ate empty capsule (placebo) for 4 weeks (week 1-4) and measured OGTT, AIR, and gut microbe examination at week 4. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sucralose | Dietary Supplement | Consumption of capsules containing either 200 mg sucralose (equivalent to diet soda 3 cans) per day for four weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| The effect of sucralose on insulin secretion | We will measure plasma insulin concentrations before and at 0, 2, 3, 4, 5, 6, 8, 10 minutes after administered intravenously 50%glucose 0.3 g/kg within 1 minute. All these data collected were used to calculate acute insulin response to glucose. | 2 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Glucagon-like peptide-1 secretion | 2 hours | |
| Gut microbiota | stool exam, polymerase chain reaction for 16s RNA gene using next generation sequencing | 4 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Chutintorn Sriphrapradang, M.D. | Ramathibodi Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Faculty of Medicine Ramathibodi Hospital, Mahidol University | Bangkok | 10400 | Thailand |
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | May 21, 2017 | |
| Reset | Oct 10, 2017 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| May 21, 2017 | Oct 10, 2017 |
| ID | Term |
|---|---|
| D007333 | Insulin Resistance |
| D005247 | Feeding Behavior |
| ID | Term |
|---|---|
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C026285 | trichlorosucrose |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Dietary Supplement | Consumption of empty capsule everyday for 4 weeks |
|
| Food record | 4 weeks |
| The effect of sucralose on insulin sensitivity | We will measure plasma insulin concentrations during an oral glucose tolerance test. | 2 hours |
| D001522 | Behavior, Animal |
| D001519 | Behavior |